Mipra, a window of opportunity study evaluating mifepristone treatment for postmenopausal breast cancer patients with higher levels of progesterone receptor isoform a than b

被引：0
|
作者：
Elia, Andres [1 ]
Vanzulli, Silvia I. [2 ]
Gass, Hugo [3 ]
Lamb, Caroline A. [1 ]
Fabris, Victoria T. [1 ]
Martinez Vazquez, Paula [3 ]
Burruchaga, Javier [3 ]
Spengler, Eunice [3 ]
Caillet Bois, Ines [3 ]
Castets, Alejandra [3 ]
Lovisi, Silvia [3 ]
Liguori, Marcos [3 ]
Pataccini, Gabriela [1 ]
Florencia Abascal, M. [1 ]
Novaro, Virginia [1 ]
Acosta Haab, Gabriela [4 ]
Molinolo, Alfredo [5 ]
Rojas, Paola [1 ]
Lanari, Claudia [1 ]
机构：
[1] Inst Biol & Med Expt, Buenos Aires, DF, Argentina
[2] Acad Nacl Med Buenos Aires, Buenos Aires, DF, Argentina
[3] Hosp Agudos Magdalena V de Martinez, Gen Pacheco, Tigre, Argentina
[4] San Isidro Patol SIP, San Isidro, Argentina
[5] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS11-35
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mifepristone treatment for breast cancer patients expressing levels of progesterone receptor isoform A (PRA) higher than those of isoform B (PRB)
    Liguori, Marcos
    Lanari, Claudia
    Gass, Hugo
    Rojas, Paola
    Elia, Andres
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gonzalez, Pedro
    Caillet Bois, Ines
    Ventura, Carla
    San Martin, Gustavo
    Castets, Alejandra
    Lovisi, Silvia
    Acosta Haab, Gabriela
    Lamb, Caroline
    Fabris, Victoria
    Novaro, Virginia
    Molinolo, Alfredo
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [2] Transcriptome modulation by mifepristone treatment in breast cancer patients with higher levels of progesterone receptor A than B
    Elia, Andres
    Abba, Martin
    Gass, Hugo
    Lamb, Caroline A.
    Fabris, Victoria T.
    Vazquez, Paula Martinez
    Burruchaga, Javier
    Spengler, Eunice
    Bois, Ines Caillet
    Castets, Alejandra
    Lovisi, Silvia
    Liguori, Marcos
    Pataccini, Gabriela
    Abascal, Maria Florencia
    Novaro, Virginia
    Molinolo, Alfredo
    Vanzulli, Silvia I.
    Rojas, Paola
    Lanari, Claudia
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [3] Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
    Elia, Andres
    Saldain, Leo
    Vanzulli, Silvia I.
    Helguero, Luisa A.
    Lamb, Caroline A.
    Fabris, Victoria
    Pataccini, Gabriela
    Martinez-Vazquez, Paula
    Burruchaga, Javier
    Caillet-Bois, Ines
    Spengler, Eunice
    Haab, Gabriela Acosta
    Liguori, Marcos
    Castets, Alejandra
    Lovisi, Silvia
    Abascal, Maria F.
    Novaro, Virginia
    Sanchez, Jana
    Munoz, Javier
    Belizan, Jose M.
    Abba, Martin C.
    Gass, Hugo
    Rojas, Paola
    Lanari, Claudia
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (05) : 866 - 877
  • [4] Proteome and RNA-Seq changes in breast cancer patients with higher levels of progesterone receptor A than B after mifepristone treatment
    Elia, A. M.
    Sanchez, J.
    Rojas, P.
    Saldain, L.
    Martinez Vazquez, P.
    Burruchaga, J.
    Spengler, E. A.
    Caillet Bois, I.
    Liguori, M. D.
    Gass, H.
    Abba, M.
    Munoz, J.
    Helguero, L.
    Lanari, C. C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S171 - S171
  • [5] Morphological changes and regulation of hormone receptor-related proteins in breast cancer patients with higher levels of progesterone receptor A than B treated with mifepristone
    Saldain, L.
    Vanzulli, S.
    Spengler, E. A.
    Elia, A. M.
    Abascal, M. F.
    Martinez Vazquez, P.
    Burruchaga, J.
    Caillet Bois, I.
    Liguori, M. D.
    Gass, H.
    Lanari, C. C.
    Rojas, P.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S145 - S146
  • [6] Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients
    Kallak, T. Kunovac
    Baumgart, J.
    Evers, A. Stavreus
    Poromaa, I. Sundstrom
    Moby, L.
    Kask, K.
    Norjavaara, E.
    Kushnir, M. M.
    Bergquist, J.
    Nilsson, K.
    [J]. CLIMACTERIC, 2012, 15 (05) : 473 - 480
  • [7] The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
    Maria Feldt
    Julien Menard
    Ann H. Rosendahl
    Barbara Lettiero
    Pär-Ola Bendahl
    Mattias Belting
    Signe Borgquist
    [J]. Cancer & Metabolism, 8
  • [8] The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial
    Feldt, Maria
    Menard, Julien
    Rosendahl, Ann H.
    Lettiero, Barbara
    Bendahl, Par-Ola
    Belting, Mattias
    Borgquist, Signe
    [J]. CANCER & METABOLISM, 2020, 8 (01)
  • [9] Progesterone receptor expression in oestrogen receptor positive breast cancers overexpressing HER-2/neu is higher in premenopausal than postmenopausal patients.
    Huang, HJ
    Neven, P
    Drijkoningen, M
    Amant, F
    Berteloot, P
    Wildiers, H
    Vanlimbergen, E
    Paridaens, R
    Christiaens, MR
    Vergote, I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S176 - S177
  • [10] The WinPro study: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer
    Lim, Elgene
    Carson, Emma
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 194 - 195
12345